Protected: Neuro 2023 Private Access

 
| By Sabrina Da Rocha
Categories: Uncategorized
CurePSP and PSPA collaborated to organize Neuro2023: The PSP and CBD International Research Symposium on October 19-20, 2023, at the Pan Pacific Hotel in London, UK, which aimed to bring together experts from all over the world to share the latest scientific breakthroughs. The symposium showcased PSP and CBD research conducted by distinguished neuroscientists and …

READ MORE

CurePSP is hiring! Join us in our mission!

 
| By Sabrina Da Rocha
Categories: News, Uncategorized
Professional Opportunity Director / Associate Director of Scientific Affairs and Partnerships Download Job Description Here The Opportunity: CurePSP seeks a Director or Associate Director of Scientific Affairs and Partnerships. This role offers the opportunity to advance key strategic initiatives and partnerships as a senior member of a leading neuroscience nonprofit. This position reports to CurePSP’s Executive Director …

READ MORE

CurePSP appoints Dr. Kristophe Diaz as the foundation’s chief executive

 
| By Sabrina Da Rocha
Categories: About us, News, Uncategorized
A scientist with broad experience in life sciences will lead the organization’s research, programs, and fundraising initiatives. NEW YORK, NY (August 9, 2021) /PRNewswire/ – CurePSP, the foundation for prime of life neurodegeneration, has named Kristophe Diaz, PhD, as its new executive director and chief scientific officer. In this planned succession, he succeeds David Kemp as …

READ MORE

CurePSP Image Library

 
| By Denise Forero
Categories: Uncategorized
Every year we are continuously growing our number of volunteers who are helping spread awareness and hosting fundraisers to support our vital programs and services. CurePSP is incredibly thankful for all of the effort and hard work that our community demonstrates. We are always looking for new ways to display everything you all do for …

READ MORE

Launching the New Forum!

 
| By Lucas Metherall
Categories: Uncategorized
CurePSP is proud to present the new forum to our community of people affected by PSP, CBD, and related prime of life brain diseases. The previous forum was a well used and much loved space for many people to reach out and connect with others going through the same journey, sharing ideas, thoughts, and words …

READ MORE

CurePSP Support Group Initiative Goes Global This Giving Tuesday.

 
| By Lucas Metherall
Categories: Uncategorized
This press release was published at 10am Wednesday, November 15, in PR Newswire.   NEW YORK, Nov. 15, 2017 /PRNewswire/ — CurePSP, the leading nonprofit advocacy organization for prime of life neurodegenerative diseases, today announced the launch of a global initiative tied to Giving Tuesday, #PiesforPSP, to support individuals and families who have been affected by …

READ MORE

New Criteria For PSP Diagnosis

 
| By Lucas Metherall
Categories: Uncategorized
New Diagnosis Criteria Established for PSP. In a groundbreaking development, an international collaboration of neurologists and movement disorder specialists have convened to agree on a a revision of the previous PSP diagnostic criteria. CurePSP has worked closely with many of the collaborators involved, and is very excited about this new development. “The new diagnostic criteria are …

READ MORE

Why Advocacy is Vital

 
| By Lucas Metherall
Categories: Support News, Uncategorized, Volunteer
Trish Caruana, Vice President - Patient and Carepartner Advocacy
In this article, Trish Caruana, Vice President – Patient and Carepartner Advocacy explains what advocacy is, and the common hurdles people face when considering advocacy. Care, consciousness and cure are central to the mission of CurePSP, but how we advocate for people with PSP and other prime of life diseases is also important. The lack of …

READ MORE

Anti-Tau Antibody Trial Enters Phase 2!

 
| By Lucas Metherall
Categories: Uncategorized
AbbVie Initiates Phase 2 Clinical Trial Programs for ABBV-8E12, an Investigational Anti-Tau Antibody, in Early Alzheimer’s Disease and Progressive Supranuclear Palsy Jan 25, 2017 Courtesy of AbbVie, January 2017   – Initiation of Phase 2 clinical trial programs in early Alzheimer’s disease and progressive supranuclear palsy (PSP) is part of ongoing commitment to investigate ABBV-8E12 …

READ MORE

CurePSP Receives Matching Grant Challenge for Genetics Research

 
| By Lucas Metherall
Categories: Research News, Uncategorized
Friedman family has committed up to $600,000 New York, NY (June 29, 2016) — CurePSP, the leading nonprofit advocacy organization focused on prime of life neurodegenerative diseases, today announced a matching grant challenge of up to $600,000 from the Friedman family to accelerate genetics research. An initial contribution of $250,000 toward this goal has been …

READ MORE